Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System

NCT06157567 is registered in ClinicalTrials.gov with Candela Corporation as lead sponsor.

NCT NCT06157567
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06157567 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System
Lead sponsor
Candela Corporation
Phase
Not applicable
Overall status
Active, not recruiting
Start date
May 24, 2022
Completion date
May 24, 2028
Enrollment
500 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

skin condition, skin laxity, wrinkle